{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:20:53Z","timestamp":1788315653751,"version":"build-2803163510"},"reference-count":48,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Technology &amp; Therapeutics"],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Obesity is increasingly prevalent in type 1 diabetes (T1D), contributing to insulin resistance and metabolic dysfunction-associated steatotic liver disease (MASLD). While semaglutide has demonstrated weight loss, improved glycemic control, and cardiovascular benefits in type 2 diabetes, its use in T1D remains unapproved.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims and Methods:<\/jats:title>\n                    <jats:p>This real-world study evaluates the effects of once-weekly semaglutide in overweight\/obese adults with T1D after 12 months of follow-up. Inclusion criteria were stable glycemic control (\u0394HbA1c &lt; 0.3%), stable body weight (\u0394weight &lt; 3%), and consistent total daily insulin requirement (TDI, \u0394TDI &lt; 5%) over the preceding year. Changes in weight, total daily insulin dose (TDI), glycated hemoglobin A1c (HbA1c), and metabolic markers, including controlled attenuation parameter (CAP) and liver stiffness measurement (LSM), were assessed at baseline and 12 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Among 42 subjects (53% male, age 46 \u00b1 12 years, diabetes duration 28 \u00b1 12 years, HbA1c 7.4 \u00b1 0.8%, body mass index 32.2 \u00b1 4.3 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      ), 76.2% had obesity. Eight subjects discontinued treatment, mainly due to gastrointestinal intolerance. Mean relative weight loss was 13.3 \u00b1 11.3% (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), with 76.4% attaining \u22655% weight loss and 61.7% attaining \u226510%. Obesity prevalence decreased to 29.4% (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). HbA1c decreased by 0.4 \u00b1 0.6% (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), with 42% achieving a reduction of \u22650.5%. No significant changes in continuous glucose monitoring-derived parameters were observed in those with available data (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 28). TDI reduced by 13.6 \u00b1 16.0% (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), whereas TDI\/kg of body weight remained stable. In 23 subjects with serial hepatic imaging, MASLD prevalence reduced from 82.6% to 30.4% (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), CAP decreased by 45 \u00b1 33 decibels\/m, and significant fibrosis (based on LSM &gt;8 kPa) declined from 20.6% to 4.5% (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Semaglutide in T1D was safe and well-tolerated and led to significant weight loss, improved glycemic control, and amelioration of MASLD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/15209156251362497","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:34:46Z","timestamp":1759250086000},"page":"27-37","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":9,"title":["Real-World Evidence of the Effect of Adjunctive Semaglutide on Weight Change, Glycemic Control, and Metabolic Dysfunction-Associated Steatotic Liver Disease in People with Type 1 Diabetes"],"prefix":"10.1177","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4822-4113","authenticated-orcid":false,"given":"Jonathan","family":"Mertens","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Diabetology &amp; Metabolism, Antwerp University Hospital, Antwerp, Belgium."},{"name":"Laboratory of Experimental Medicine and Paediatrics and member of the Infla-Med Centre of Excellence, Faculty of Medicine &amp; Health Sciences, University of Antwerp, Antwerp, Belgium."},{"name":"Department of Gastroenterology &amp; Hepatology, Antwerp University Hospital, Antwerp, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hennah T.","family":"De Winter","sequence":"additional","affiliation":[{"name":"Faculty of Medicine &amp; Health Sciences, University of Antwerp, Antwerp, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveline","family":"Dirinck","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology &amp; Metabolism, Antwerp University Hospital, Antwerp, Belgium."},{"name":"Laboratory of Experimental Medicine and Paediatrics and member of the Infla-Med Centre of Excellence, Faculty of Medicine &amp; Health Sciences, University of Antwerp, Antwerp, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Francque","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Medicine and Paediatrics and member of the Infla-Med Centre of Excellence, Faculty of Medicine &amp; Health Sciences, University of Antwerp, Antwerp, Belgium."},{"name":"Department of Gastroenterology &amp; Hepatology, Antwerp University Hospital, Antwerp, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"De Block","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology &amp; Metabolism, Antwerp University Hospital, Antwerp, Belgium."},{"name":"Laboratory of Experimental Medicine and Paediatrics and member of the Infla-Med Centre of Excellence, Faculty of Medicine &amp; Health Sciences, University of Antwerp, Antwerp, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2307563"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2032183"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607141"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2403347"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03327-6"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01185-6"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-0749"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1901118"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(19)30192-5"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad471"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-0691"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-0690"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03463-z"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2023.0490"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2024.111593"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2024.0328"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1177\/19322968241291512"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1177\/20420188211055557"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100753"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15723"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae015"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae175"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0911"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00246-1"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc25-S002"},{"issue":"1","key":"e_1_3_3_27_2","first-page":"S20","article-title":"2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2024","volume":"47","year":"2024","unstructured":"2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2024. Diabetes Care, 2024; 47(Suppl 1):S20\u2013S42.","journal-title":"Diabetes Care"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.2337\/dci19-0028"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.49.4.626"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2021.101761"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.01.042"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.04.031"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.05.025"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-6-33"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.453"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1988.10478722"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-024-06273-7"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.2337\/dci21-0043"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-023-01429-8"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30014-1"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/dom.16300"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30043-7"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30013-X"},{"key":"e_1_3_3_44_2","article-title":"Global epidemiology and characteristics of MASLD in type 1 diabetes mellitus: An updated systematic review and meta-analysis","author":"Souza M","year":"2024","unstructured":"Souza M, , Al-Sharif L, , Khalil SM, et al. Global epidemiology and characteristics of MASLD in type 1 diabetes mellitus: An updated systematic review and meta-analysis. Clin Gastroenterol Hepatol, 2024.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02145-x"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-0475"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-0433"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-01791-x"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0960"}],"container-title":["Diabetes Technology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/15209156251362497","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15209156251362497","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15209156251362497","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:19:08Z","timestamp":1777400348000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/15209156251362497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,1]]}},"alternative-id":["10.1177\/15209156251362497"],"URL":"https:\/\/doi.org\/10.1177\/15209156251362497","relation":{},"ISSN":["1520-9156","1557-8593"],"issn-type":[{"value":"1520-9156","type":"print"},{"value":"1557-8593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,24]]}}}